Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Trustee : the Journal for Hospital Governing Boards|March 31, 2012
How to build an ACO: Medicare's shared savings program includes specific structural and governance requirementsCraig H SmithJournal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 4, 2009
Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis populationCraig H Smith, Emmanuelle Waubant, Annette Langer-GouldRetina (Philadelphia, Pa.)|April 24, 2013
Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot studyPeter K Kaiser, Yi-Zhong Wang, Yu-Guang He, et al.Biomarkers in Medicine|August 31, 2023
Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19Pavan K Bhatraju, Eric D Morrell, Nicholas G O'Connor, et al.Annals of Neurology|May 4, 2010
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?Amit Bar-Or, Lama Fawaz, Boli Fan, et al.Annals of Neurology|October 23, 2009
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trialKathleen Hawker, Paul O'Connor, Mark S Freedman, et al.The New England Journal of Medicine|February 15, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosisStephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, et al.Critical Care Explorations|July 17, 2023
Biomarker Signatures of Severe Acute Kidney Injury in a Critically Ill Cohort of COVID-19 and Non-COVID-19 Acute Respiratory IllnessNeha A Sathe, Ana Mostaghim, Elizabeth Barnes, et al.Annals of Neurology|April 3, 2008
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trialAmit Bar-Or, Peter A J Calabresi, Douglas Arnold, et al.Plos Neglected Tropical Diseases|June 11, 2015
Prioritising Infectious Disease MappingDavid M Pigott, Rosalind E Howes, Antoinette Wiebe, et al.Pageof 2